Consumer studies highlight OTC drug pricing gaps and efficacy concerns

Recent studies highlight significant concerns regarding the cost and efficacy of over-the-counter (OTC) medications. An investigation by DECO PROteste into 138 establishments found that health spaces within supermarkets consistently offer lower prices for non-prescription drugs compared to traditional pharmacies. For example, the average price of Daflon 1000 mg was approximately 20% lower in supermarkets than in pharmacies. While competition was intended to lower costs, the study noted that the cost of a sample basket of 26 products rose from 251.86 euros to 278.39 euros compared to 2024.

Parallel to pricing concerns, a study by 60 Millions de consommateurs warns of the risks associated with self-medication. After analyzing over 100 OTC products, including supplements and medical devices, researchers found that only 15% met the criteria for both efficacy and safety. Approximately 44% of the products were deemed ineffective but harmless, while 35 products were classified as problematic. Experts warn that relying on ineffective products can lead to financial waste and, more critically, may delay necessary professional medical intervention.